The power of artificial intelligence (AI) in medicine lies in its ability to find important statistical patterns in large datasets. A study published today is an important proof of concept for how AI can help doctors and brain tumour patients make better treatment decisions.
Open source app helps predict brain tumour malignancy and patient survival
The power of artificial intelligence (AI) in medicine lies in its ability to find important statistical patterns in large datasets. A study published today is an important proof of concept for how AI can help doctors and brain tumour patients make better treatment decisions.
Providing excellent care and the latest research to help patients
The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed by Kevin Petrecca and Frédéric Leblond
Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.
A Brilliant Night has donated a total of $1.6 million since 2015
A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.
Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cellsÂ
Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers.Â
<p>October is Brain Tumour Awareness Month</p>
October is Brain Tumour Awareness Month